Skip to main content
. 2023 Feb 23;9:e2200331. doi: 10.1200/GO.22.00331

FIG 4.

FIG 4

Anti–SARS-CoV-2 IgG seroconversion rates after COVID-19 vaccination (all vaccine). The anti–SARS-CoV-2 IgG seroconversion rates between the CMT and non-CMT groups at 4 weeks after two-dose vaccination were 78.9% (95% CI, 68.1 to 87.5) and 96.5% (95% CI, 80.1 to 99.3), respectively, P = .001. The grey bars indicate 95% CIs. CMT, chemotherapy; IgG, immunoglobulin G; non-CMT, nonchemotherapy.